The Continua Health Alliance is a nonprofit organization comprised of healthcare and technology companies working collaboratively to establish universal standards for personal health systems. Its mission is to create an interoperable ecosystem that empowers individuals to better manage their health. The Alliance currently has over 176 member companies. It addresses the growing challenges of chronic disease management by extending healthcare monitoring into the home through technologies that allow remote collection of vital signs, images, and communication between patients and care teams.
LifeScience Alley boasts a membership of 650 organizations and branches. For 30 years we have been viewed as a leader in Medtech. Our members know that we care, we can be trusted with sensitive information, and we are a valuable investment into the future of their business.
The smartphone hype has brought some exciting changes to the traditional mobile health industry. This research paper contains a survey amongst companies developing mobile health applications.
The survey reveals that the impact the new smartphone app market has on mHealth is significant.
In total we had 231 participating companies ranging from start-up mHealth specialists to traditional healthcare market players.
LifeScience Alley boasts a membership of 650 organizations and branches. For 30 years we have been viewed as a leader in Medtech. Our members know that we care, we can be trusted with sensitive information, and we are a valuable investment into the future of their business.
The smartphone hype has brought some exciting changes to the traditional mobile health industry. This research paper contains a survey amongst companies developing mobile health applications.
The survey reveals that the impact the new smartphone app market has on mHealth is significant.
In total we had 231 participating companies ranging from start-up mHealth specialists to traditional healthcare market players.
Connected Health is the way forward!
By improving this we can improve the Health of all. Advances in new technologies are being developed and implemented everyday. The key factor that connects and delivers all of these advances are health professionals.
Stredia are at the forefront of these innovative changes: Driving clinical improvement by engaging and supporting staff.
MEDICA MEDIA FORUM
„ePatient/Health 2.0: Schlüsselfaktor für neue, zukunftsfähige Geschäftsmodelle der Life Sciences Industrie“
Impulsreferat von Matthias Wartenberg, Executive Director Advisory Service LifeScience, Ernst & Young, Eschborn
HorseTech Conference Cheltenham 15/16 March 20223GDR
Speakers who will present on 15-16th March 2022 at the HorseTech Conference Cheltenham (and can be watched via the completely FREE livestream). For full details and to register:
https://horsetechconference.com/cheltenham/
DOCTORS AND SOCIAL MEDIA webinar (delivered by Liz Price, MDDUS senior risk a...3GDR
These slides were used for a MDDUS webinar that aimed to explore the legislative and regulatory risks involved in doctors personal and professional use of social media, and in relation to responding to and engaging with patients via this media.
The objectives were to raise awareness of the common medicolegal risks associated with doctors personal use of social media.
To raise awareness of the common medicolegal risks associated with doctors professional use of social media. To explore ways in which doctors can most appropriately respond to patient feedback and contacts via online platforms.
Participants are equipped to apply the knowledge gained in the webinar to risk assess and safely manage their online activities.
Provides guidance to enable improvement of personal practice in this area:
More Related Content
Similar to Continua Alliance: The Next Generation of TeleHealth
Connected Health is the way forward!
By improving this we can improve the Health of all. Advances in new technologies are being developed and implemented everyday. The key factor that connects and delivers all of these advances are health professionals.
Stredia are at the forefront of these innovative changes: Driving clinical improvement by engaging and supporting staff.
MEDICA MEDIA FORUM
„ePatient/Health 2.0: Schlüsselfaktor für neue, zukunftsfähige Geschäftsmodelle der Life Sciences Industrie“
Impulsreferat von Matthias Wartenberg, Executive Director Advisory Service LifeScience, Ernst & Young, Eschborn
Similar to Continua Alliance: The Next Generation of TeleHealth (20)
HorseTech Conference Cheltenham 15/16 March 20223GDR
Speakers who will present on 15-16th March 2022 at the HorseTech Conference Cheltenham (and can be watched via the completely FREE livestream). For full details and to register:
https://horsetechconference.com/cheltenham/
DOCTORS AND SOCIAL MEDIA webinar (delivered by Liz Price, MDDUS senior risk a...3GDR
These slides were used for a MDDUS webinar that aimed to explore the legislative and regulatory risks involved in doctors personal and professional use of social media, and in relation to responding to and engaging with patients via this media.
The objectives were to raise awareness of the common medicolegal risks associated with doctors personal use of social media.
To raise awareness of the common medicolegal risks associated with doctors professional use of social media. To explore ways in which doctors can most appropriately respond to patient feedback and contacts via online platforms.
Participants are equipped to apply the knowledge gained in the webinar to risk assess and safely manage their online activities.
Provides guidance to enable improvement of personal practice in this area:
Royal Pharmaceutical Society UCL School of Pharmacy New Year Lecture 20193GDR
Diabetes and the Pharmacy Army
Philip Newland-Jones
Consultant Pharmacist Diabetes & Endocrinology
University Hospital Southampton NHS Foundation Trust
Mobile Health: the enable of Empowered Patients3GDR
Draft of slides for talk by David Doherty (coFounder, 3GDoctor) at the "Transforming Community Pharmacies in to High Street Clinics" Conference in London on the 15th November 2018.
For more information please visit:
https://mhealthinsight.com/2018/10/28/join-us-at-transforming-community-pharmacies-in-to-high-street-clinics/
Mobile Health: the enable of Empowered Patients3GDR
Draft of slides for talk by David Doherty (coFounder, 3GDoctor) at the "Transforming Community Pharmacies in to High Street Clinics" Conference in London on the 15th November 2018.
Slides for lecture by David Doherty (about.me/mHealth) to the Medical Students at University College Dublin on Thursday 29th March 2018.
Full details and Video:
https://mhealthinsight.com/2018/03/22/how-would-the-bornmobile-generation-redesign-medicine-and-whats-the-future-role-of-the-doctor/
Slides for lecture by David Doherty (about.me/mHealth) to the Medical Students at University College Dublin on Thursday 22 March 2018.
Full details and Video:
https://mhealthinsight.com/2018/03/22/how-would-the-bornmobile-generation-redesign-medicine-and-whats-the-future-role-of-the-doctor/
eHealth Ireland & Northern Ireland Connected Health Ecosystem
members of the ECHAlliance International Ecosystem Network
Cross Border Collaboration Projects in Action Alan Connor, mPower Programme Manager, NHS24
Notes on a talk on “Pricing and evaluating Orphan Drugs – present and future”...3GDR
The following slides are notes made by David Doherty following a very interesting presentation on “Pricing and evaluating Orphan Drugs – present and future” provided by Goran Medic, Market Access Manager Europe at Horizon Pharma Plc at the Pharma Pricing & Market Access Europe Conference in London (the world’s largest gathering of pharmaceutical pricing, market access and reimbursement professionals) on the 23rd February 2017.
Deriving more value from real world evidence to ensure timely access of medic...3GDR
Dr Sarah Wamala Andersson, Consultant, Real world evidence and value-based medicines
Pharma Pricing & Market Access Congress 2017 22 February 2017 London
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Continua Alliance: The Next Generation of TeleHealth
1. Continua Health Alliance:
The Next Generation of Personal
Telehealth is Here
A non-profit, open industry alliance of the finest
healthcare and technology companies in the world
joining together in collaboration to improve the
quality of personal healthcare.
2. The Continua Health Alliance
“Our Mission is to
establish an eco-system
of interoperable
personal health systems
that empower people &
organizations to better
manage their health and
wellness”
4. Over 176
Contributors Member
Companies!
Lifescan TaiDoc Technology Corporation
Alere Medical, Inc. Duodecim Medical Publications
LS Research, LLC Tanita Corporation
Allion Test Labs, Inc. Dynastream Innovations Inc.
MEDCEL TechnoGym
All Medicus Co., Ltd. Ember Corporation
Medixine Oy Tekoa Technologies Inc.
American Heart Association Empirica GmbH
MedSignals Telbios, SpA
Analog Devices ETRI
MedTech Systems Inc. Telecom Italia SpA
Analogic Corp. EuroTech, Inc.
Microlife Corporation Telefonica S.A.
Andago Ingenieria s.l. Fairbanks Scales
Midmark Corporation Telehealth Solutions Ltd.
AppsHub, Inc. FitLinxx
Misys Healthcare Systems TeleMedCare Pty Ltd.
AT4 Wireless Foundation for Research and
Technology Molex Inc. Telus Communications Company
AT&T Mobility
France Telecom R&D, LLC Monitray, LLC Terumo Corporation
AViTA
Freescale Semiconductor Motorola Textronics Inc.
BiancaMed
Frontline Test Equipment MIR- Medical International Research The Scottish Centre for Telehealth
BIOSPACE Co., Ltd.
Fujitsu Limited Neusoft Medical Systems Toshiba Home Appliances Corporation
Bluegiga Technologies Oy
Fullpower Technologies Nippon Telegraph and Telephone Toumaz Technology Limited
Boston Scientific
Corporation
GC Healthcare Corp. Triage Wireless Inc.
British Telecommunications
Nitto Denko Corporation
GenerationOne, Inc. Tyco Electronics
Cambridge Consultants Ltd.
Novo Nordisk
GlaxoSmithKline Tynetec Ltd
Capital Health
ON Semiconductor
Google Inc. UnitedHealth Group
Card Guard AG
Oracle
Hitachi, Ltd. University of Miami - Miller School of
Cardiff University
Oregon Medical Labs Medicine
Home Guardian, LLC
Cardiomedix Inc.
Oregon Scientific Inc. Verizon
HoMedics
CELS, Ltd.
Pfizer VivoMetrics, Inc.
Honeywell HomMed LLC
Centre for Global eHealth Innovation
Precor Fitness VTT Technical Research Centre of
Hosiden Corporation
Cerner Corporation
Finland
Proskauer Rose LLP
Industrial Technology Research
Chiptech Limited
Westchester Institute for Human
Institute Proteus Biomedical, Inc.
Christus Health Development
Infineon Technologies RMD Networks
Chunghwa Telecom Co., Ltd. Whole Health Management
INFORSON Co., Ltd. Ryoyo Electro Corporation
Claricode, Inc. Wipro
InfraRed Integrated Systems Ltd. Sensor Technology & Devices Ltd
Computerized Screening, Inc. Zarlink Semiconductor
Innomed Medical Zrt. Shimmer Research
ConnectBlue AB Zensys
In Practice Systems Limited SHL Telemedicine
Continuity Health
Institute for Infocomm Research Silicon and Software Systems
Convergence Wireless, Inc.
Institute of Biomedical Smartlife Technology Ltd
CSR plc
InterComponentWare, Inc. Sony Electronics Inc.
CYPAK AB
Konami Sports and Life Southern Nevada Wellness
Cypress Semiconductor
LAXTHA Inc. Stichting IMEC – Nederland
Dell
LG CNS Stollmann E+V GmbH
Digi International
LifeGate, Inc. STMicroelectronics
Dossia Consortium
Dovetail Health
5. The Challenge & The Opportunity
Worldwide today:
– 1 billion adults
overweight
– 860 million chronic
disease patients
– 600 million elders
age 60 or older
– 75-85% of healthcare
spending is on chronic
disease management
Source: World Health Organization; McKinsey
6. Health and Wellness
One billion adults overweight world wide
Health and Wellness In the future…
Extension of healthcare system
“Worried well” vital sign into the home
monitoring: Initial triage of non-emergency
– Weight conditions
– Blood pressure – Vital signs
– Glucose – Images
– Cholesterol – Email / chat / video
– Activity level
Healthy
Family
Glucose
Continua member companies help people live
Meter
healthier, more active lives by connecting
them to their health and wellness team
Blood-pressure
through a more efficient exchange of their
Cuff
personal fitness information.
Cell Phone
Digital
Pedometer
Home
Weight
Scale
Internet Personal
Weight loss Healthcare
Fitness
Health
and fitness Professionals
Equipment
Record
coaching
PC
Medication
Tracking
7. Disease Management
860 million chronic disease patients world wide
Disease Management
Vital sign monitoring (remote patient monitoring)
Chronic disease
Post trauma
Pre-op
Implant
Continua member companies help people
Pulse
Ox with chronic conditions live healthier lives by
connecting them to their care team through
Blood-pressure
a more efficient exchange of personal health
Cuff
Cell Phone information.
Digital
Pedometer
Home
Weight
Scale
Internet
PC Personal
Family Disease Healthcare
Fitness
Health
Care Management Provider
Equipment
Record
Givers Service
Personal
Health System
Medication
Tracking
8. Aging Independently
600 million elderly individuals world wide
Aging Independently
Basic life monitoring as
appropriate (ADL):
– Bed pressure (sleep)
– Bathroom sensor
– Gas / water sensor
Independent – Emergency sensor
living
Chronic disease
Implant
Continua member companies help the
Pulse
Ox elderly age independently, with dignity and
security, through the efficient exchange of
Blood-pressure
personal health and safety information that
Cuff
Cell Phone connects them to their family and care team.
Digital
Pedometer
Home
Home
Automation
and Control
Internet
PC Disease
Family Elderly Diet and
Fitness
Management
Care Monitoring Wellness
Equipment
Service,
Givers Services Services
Personal Healthcare
Health System Provider
Medication
Tracking
9. Version One Device Connectivity Standards
Pulse
Oximeter
ISO/IEEE 11073-10404 = Pulse Oximeter
PC
ISO/IEEE 11073-10406 = Pulse / Heart Rate
ISO/IEEE 11073-10407 = Blood Pressure
Pulse /
ISO/IEEE 11073-10408 = Thermometer
Blood Pressure
ISO/IEEE 11073-10415 = Weighing Scale
Personal
ISO/IEEE 11073-10417 = Glucose
Health System
ISO/IEEE 11073-10441 = Cardiovascular Fitness Monitor
Weight
ISO/IEEE 11073-10442 = Strength Fitness Equipment
Scale
ISO/IEEE 11073-10471 = Independent Living Activity
ISO/IEEE 11073-10472 = Medication Monitor
Glucose Cell Phone
Meter
Cardiovascular
and Strength
Fitness Monitor
Bluetooth Medical
Set Top Box
Independent Device Profile Specification
Living Activity
Medication
Monitor
USB Personal Healthcare Aggregator
Device Class Specification
10. Version One Healthcare Record Standards
Disease Management
Healthcare Provider
Continua xHR Interface
Service Provider
(Data, Message, Security)
Electronic
Remote
Health Record
Patient
Labs
System
Disease Monitoring
management (RPM) Server
nurse or home
care nurse
Home-based Remote
Patient Monitoring
(RPM) System
Patient
EHR
Vital Sign Devices
11. Ecosystem Development
Certification
Developer Resources
Test and certification tools
Web-based environment
Right to use certified logo upon
(repository, collaboration tools)
completion of successful
Reference source code
certification
Market Intelligence Collaboration
Plugfests participation
Access to market research data
Participation in RFP MatchMaker
Access to pre-publication drafts of
program
the design guidelines
Unlimited participation in Continua
Internal and external education and
quarterly summits, town hall
training meetings, and education seminars
Wednesday, December 03, 2008
12. Guidelines Certification Recognizable Logo
Electronic Media / Software
Guidelines
Continua member companies will
select connectivity standards and
publish Guidelines for strict
interoperability.
Certification and Logo
Product Packaging
Continua is establishing a test and
certification program with a
recognizable logo signifying the
promise of interoperability with
other certified products.
Product Applications Product Substrates
13. Save $500-600K
Free Reference Source Code on Product
Development!
Source Code Library
500 modules of member-written source code already available in our
library…downloaded by dozens of companies
We are paying contractors to write the rest. Planning on $1M in
2008…add more code to the library each year
Structured as library of modules w/ API
Reference code only—use at your own risk (disclaimer)
Generic Reference Platform
Not optimized for a specific device:
Operating system: Windows XP
Hardware: X86-based
Language: C/C++
Implement Mandatory Features of Guidelines
14. First Plugfest—April, 2008 Luxembourg
V1 PAN Interface Using ISO/IEEE PHD Standards
10 Companies
2 PAN Interface Transports
7 Devices
Blood
Cardio Glucose Pulse Medication Pressure Weighing Thermometer
Scale
Meter Oximeter Monitor Monitor
15. First Public Interoperability Demonstration
Harvard Medical Amphitheater | October 27, 2008
XHR Interface
Heart Failure & COPD
Device Interface
EHR
Wireless Pulse Oximeter
Telehealth
Service
PHR
Weighing Scale Obesity & Diabetes
Telehealth
Service
EHR
Blood Pressure Monitor
Telehealth
Service
16. Let Continua
Continua Matchmaking help you
find partners!
The Continua Matchmaking Program: Helping
members and non-members find solutions for new
health and chronic disease management programs
Help healthcare providers find world class vendors who are
developing the next generation of personal telehealth devices and
services
Come to our website, fill out a simple RFP-like form and submit it.
Our Continua vendor community will receive notification and
contact you
http://www.continuaalliance.org/match_program
17. Building Awareness Around the World…
London
January 2007
Luxembourg
Ireland
Boston
San Francisco April 2008 Tokyo
January 2008
October 2006
June 2006
April 2007
Boston
San Francisco
October 2007
June 2007
San Francisco Boston
June 2008 October 2008
Continua
sponsored public 2009: Tokyo, Barcelona, Vancouver B.C., Boston
symposiums and
Tentative 2010: Singapore, Brussels, Africa, Seattle
member summits